LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

Search

Zai Lab Ltd ADR

Затворен

СекторЗдравеопазване

31.28 -3.72

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

30.68

Максимум

32.35

Ключови измерители

By Trading Economics

Приходи

33M

-48M

Продажби

-2.6M

106M

EPS

-0.45

Марж на печалбата

-45.487

Служители

1,869

EBITDA

19M

-56M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+62% upside

Дивиденти

By Dow Jones

Следващи печалби

5.08.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

194M

3.6B

Предишно отваряне

35

Предишно затваряне

31.28

Настроения в новините

By Acuity

23%

77%

50 / 382 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

Zai Lab Ltd ADR Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

23.05.2025 г., 20:33 ч. UTC

Придобивния, сливания и поглъщания

Salesforce in Talks to Buy Informatica, Bloomberg Reports, Citing Sources

23.05.2025 г., 21:57 ч. UTC

Горещи акции

Stocks to Watch: Apple, Booz Allen, Constellation Energy, Intuit -- WSJ

23.05.2025 г., 21:15 ч. UTC

Топ новини

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23.05.2025 г., 21:04 ч. UTC

Придобивния, сливания и поглъщания

Real-Estate Broker Douglas Elliman Could See Takeover Battle After Report of Bid -- Barrons.com

23.05.2025 г., 20:56 ч. UTC

Топ новини
Придобивния, сливания и поглъщания

Salesforce Back in Deal Talks With Informatica -- WSJ

23.05.2025 г., 20:51 ч. UTC

Топ новини

Boeing in Tentative Agreement to Pay $1.1 Billion to Avoid Trial for 737 MAX Crashes -- WSJ

23.05.2025 г., 20:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

23.05.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

23.05.2025 г., 20:41 ч. UTC

Топ новини

Stocks Fall on Tariff Broadside, After Week of Bond Market Agita -- WSJ

23.05.2025 г., 20:28 ч. UTC

Топ новини

Trump Threatens EU With 50% Tariffs, Takes Aim at Apple; Nasdaq Drops -- WSJ

23.05.2025 г., 20:06 ч. UTC

Топ новини

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 5th Update

23.05.2025 г., 20:06 ч. UTC

Придобивния, сливания и поглъщания

Salesforce Stock Drops, Informatica Soars. A Deal May Be Back on the Table. -- Barrons.com

23.05.2025 г., 19:50 ч. UTC

Топ новини

Trump's Tariffs: Where Things Stand -- 16th Update

23.05.2025 г., 19:28 ч. UTC

Придобивния, сливания и поглъщания

Trump on Truth Social: 'Bulk of That Investment Will Occur in the Next 14 Months'

23.05.2025 г., 19:28 ч. UTC

Придобивния, сливания и поглъщания

Trump on Truth Social: 'This Will Be a Planned Partnership Between United States Steel and Nippon Steel'

23.05.2025 г., 19:27 ч. UTC

Придобивния, сливания и поглъщания

Trump on Truth Social: 'Proud to Announce That, After Much Consideration and Negotiation, US Steel Will REMAIN in America'

23.05.2025 г., 19:20 ч. UTC

Пазарно говорене

Crude Futures Post Modest Weekly Losses -- Market Talk

23.05.2025 г., 19:18 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures End Week Unchanged -- Market Talk

23.05.2025 г., 18:57 ч. UTC

Топ новини

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23.05.2025 г., 18:54 ч. UTC

Топ новини

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- Update

23.05.2025 г., 18:53 ч. UTC

Топ новини
Придобивния, сливания и поглъщания

McDonald's Bids Goodbye to CosMc's, Its Space Alien-Themed Spinoff -- WSJ

23.05.2025 г., 18:52 ч. UTC

Придобивния, сливания и поглъщания

DDC Enterprise Issues 254,333 Class A Ordinary Shrs in Exchange for 21 BTC, Valued at About $2.28M in Current Market Price

23.05.2025 г., 18:13 ч. UTC

Пазарно говорене

Market Talk Roundup: Latest on U.S. Politics

23.05.2025 г., 18:13 ч. UTC

Пазарно говорене

Gold Trades Higher on Reminder of Risk -- Market Talk

23.05.2025 г., 18:00 ч. UTC

Топ новини

Apple's Stock Still Not Pricing in Trump's Demands - Heard on the Street -- WSJ

23.05.2025 г., 17:51 ч. UTC

Пазарно говорене
Печалби

Workday Sees Higher Bar for Guidance -- Market Talk

23.05.2025 г., 17:42 ч. UTC

Топ новини

Dow Drops, Trump Threatens EU With 50% Tariffs, Takes Aim at Apple -- WSJ

23.05.2025 г., 17:39 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Falls to Lowest Level Since November 2021 -- Market Talk

23.05.2025 г., 17:07 ч. UTC

Топ новини

Trump's Tariffs: Where Things Stand -- 15th Update

23.05.2025 г., 17:04 ч. UTC

Пазарно говорене
Печалби

Workday Appears to Have Upside Potential on Conservative Outlook -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Zai Lab Ltd ADR Прогноза

Ценова цел

By TipRanks

62% нагоре

12-месечна прогноза

Среден 52.65 USD  62%

Висок 73 USD

Нисък 32.6 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Zai Lab Ltd ADR през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

6 ratings

5

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

28.13 / 31.12Подкрепа & съпротива

Краткосрочен план

Very Strong Bearish Evidence

Средносрочен план

Bearish Evidence

Дългосрочен план

Bullish Evidence

Настроение

By Acuity

50 / 382 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.